These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34963481)

  • 1. The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China.
    Zhao ZY; Niu Y; Luo L; Hu QQ; Yang TL; Chu MJ; Chen QP; Lei Z; Rui J; Song CL; Lin SN; Wang Y; Xu JW; Zhu YZ; Liu XC; Yang M; Huang JF; Liu WK; Deng B; Liu C; Li ZY; Li PH; Su YH; Zhao BH; Huang WL; Frutos R; Chen TM
    Infect Dis Poverty; 2021 Dec; 10(1):140. PubMed ID: 34963481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiological characteristics and effectiveness of countermeasures to contain coronavirus disease 2019 in Ningbo City, Zhejiang Province, China.
    Lao X; Luo L; Lei Z; Fang T; Chen Y; Liu Y; Ding K; Zhang D; Wang R; Zhao Z; Rui J; Zhu Y; Xu J; Wang Y; Yang M; Yi B; Chen T
    Sci Rep; 2021 May; 11(1):9545. PubMed ID: 33953243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological Characteristics and Transmissibility for SARS-CoV-2 of Population Level and Cluster Level in a Chinese City.
    Yu S; Cui S; Rui J; Zhao Z; Deng B; Liu C; Li K; Wang Y; Yang Z; Li Q; Chen T; Wang S
    Front Public Health; 2021; 9():799536. PubMed ID: 35118044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Travel Restrictions of Wuhan City Against COVID-19: A Modified SEIR Model Analysis.
    Li Y; Hou S; Zhang Y; Liu J; Fan H; Cao C
    Disaster Med Public Health Prep; 2022 Aug; 16(4):1431-1437. PubMed ID: 33413723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mask wearing in pre-symptomatic patients prevents SARS-CoV-2 transmission: An epidemiological analysis.
    Hong LX; Lin A; He ZB; Zhao HH; Zhang JG; Zhang C; Ying LJ; Ge ZM; Zhang X; Han QY; Chen QY; Ye YH; Zhu JS; Chen HX; Yan WH
    Travel Med Infect Dis; 2020; 36():101803. PubMed ID: 32592903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Wuhan lockdown on the spread of COVID-19 in China: a study based on the data of population mobility.
    Wang S; Ye Y; Hu K; Lei H; Chen C; Xu X; Li W; Yuan C; Cao S; Wang S; Li S; Jia J; Wang Q; Bian Z; Wu X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):61-67. PubMed ID: 34117846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study.
    Lin SN; Rui J; Chen QP; Zhao B; Yu SS; Li ZY; Zhao ZY; Wang Y; Zhu YZ; Xu JW; Yang M; Liu XC; Yang TL; Luo L; Deng B; Huang JF; Liu C; Li PH; Liu WK; Xie F; Chen Y; Su YH; Zhao BH; Chiang YC; Chen TM
    Infect Dis Poverty; 2021 Apr; 10(1):53. PubMed ID: 33874998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of transmissibility and measures effectiveness of SARS in 8 regions, China, 2002-2003.
    Rui J; Qu H; Zhang S; Liu H; Wei H; Abudunaibi B; Li K; Zhao Y; Liu Q; Fang K; Gavotte L; Frutos R; Chen T
    Front Cell Infect Microbiol; 2023; 13():1212473. PubMed ID: 37637464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings.
    Ji T; Chen HL; Xu J; Wu LN; Li JJ; Chen K; Qin G
    Clin Infect Dis; 2020 Sep; 71(6):1454-1460. PubMed ID: 32255183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the Effects of High-Speed Railway Transfers in the Early COVID-19 Cross-Province Transmission in Mainland China.
    Chan CH; Wen TH
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34199158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating asymptomatic, undetected and total cases for the COVID-19 outbreak in Wuhan: a mathematical modeling study.
    Huo X; Chen J; Ruan S
    BMC Infect Dis; 2021 May; 21(1):476. PubMed ID: 34034662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic Characteristics of COVID-19 in Four Chinese Cities.
    Hu J; Rao S; Hu X
    Jpn J Infect Dis; 2020 Nov; 73(6):473-475. PubMed ID: 32475873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling and assessing the effects of medical resources on transmission of novel coronavirus (COVID-19) in Wuhan, China.
    Wang LP; Wang J; Zhao HY; Shi YY; Wang K; Wu P; Shi L
    Math Biosci Eng; 2020 Mar; 17(4):2936-2949. PubMed ID: 32987508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between changes in population mobility in response to the COVID-19 pandemic and socioeconomic factors at the city level in China and country level worldwide: a retrospective, observational study.
    Liu Y; Wang Z; Rader B; Li B; Wu CH; Whittington JD; Zheng P; Stenseth NC; Bjornstad ON; Brownstein JS; Tian H
    Lancet Digit Health; 2021 Jun; 3(6):e349-e359. PubMed ID: 34045001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020.
    Han H; Yi J; Cheng G; Jiang W; Brożek GM; Jiang Y; Zhu C; Xia Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33883260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.